Overview

A Study of CAR-T Cells in Subjects With Autoimmune Diseases

Status:
NOT_YET_RECRUITING
Trial end date:
2028-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with autoimmune diseases.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Chinese PLA General Hospital
Treatments:
Immunotherapy, Adoptive